Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL691429 | 1.00 | HCAR2 (0.56) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL27110712 | 1.00 | HCAR2 (0.56) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL29237067 | 0.83 | HCAR2 (0.57) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL30969581 | 0.83 | HCAR2 (0.57) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL1882129 | 0.83 | HCAR2 (0.38) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL28414984 | 0.82 | HCAR2 (0.56) | HCAR2CA12AKR1B10CA1CA2 | |
| Butane SCHEMBL15751306 | 0.81 | HCAR2 (0.67) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL8118802 | 0.80 | HCAR2 (0.54) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL27731569 | 0.80 | HCAR2 (0.54) | HCAR2CA12AKR1B10CA1CA2 | |
| SCHEMBL4449228 | 0.80 | HCAR2 (0.54) | HCAR2CA12AKR1B10CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745141-A1 | METHOD FOR PREPARING INTERMEDIATE OF ADRENERGIC RECEPTOR AGONIST | Porton Pharma Solutions Ltd. (CN) | 2026-05-20 | — | — | EP | disclosed |
| US-20260085072-A1 | METHOD FOR PREPARING INTERMEDIATE OF ADRENERGIC RECEPTOR AGONIST | PORTON PHARMA SOLUTIONS LTD (CN) | 2026-03-26 | — | — | US | disclosed |
| CN-101965330-B | Method for producing beta-mercapto carboxylic acids | SHOWA DENKO KK | 2014-07-23 | — | — | CN | disclosed |
| EP-1666440-B1 | METHOD FOR PRODUCING AROMATIC UNSATURATED COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2014-01-22 | — | — | EP | disclosed |
| EP-2268614-B1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2013-05-15 | — | — | EP | disclosed |
| US-8258340-B2 | Method for producing β-mercapto carboxylic acids | SHOWA DENKO K.K. (JP) | 2012-09-04 | — | — | US | disclosed |
| EP-2205557-B1 | METHOD FOR PRODUCING BETA-MERCAPTOCARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-7939674-B2 | Process for producing an aromatic unsaturated compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-10 | — | — | US | disclosed |
| CN-101965330-A | Method for producing beta-mercapto carboxylic acids | SHOWA DENKO KK | 2011-02-02 | — | — | CN | disclosed |
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2011-01-20 | — | — | US | disclosed |
| US-20080221337-A1 | Process for Producing an Aromatic Unsaturated Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-09-11 | — | — | US | disclosed |
| EP-1666440-A1 | METHOD FOR PRODUCING AROMATIC UNSATURATED COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2006-06-07 | — | — | EP | disclosed |
| EP-0650476-B1 | PERIPHERAL VASODILATING AGENT CONTAINING N-ACYLATED 4-AMINO PIPERIDINE DERIVATIVES AS ACTIVE INGREDIENTS | OTSUKA PHARMA CO LTD (JP) | 2002-06-26 | — | — | EP | disclosed |
| US-6136826-A | AMINOPIPERIDINE COMPOUNDS SUBSTITUTED WITH ALKANOYL | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2000-10-24 | — | — | US | disclosed |
| CN-1052224-C | Peripheral Vasodilating agent containing N-acylated 4-amino piperidine derivatives as active ingredients | OTSUKA PHARMA CO LTD (JP) | 2000-05-10 | — | — | CN | disclosed |
| US-5760058-A | Peripheral vasodilating agent containing piperidine derivative as active ingredient | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-02 | — | — | US | disclosed |
| US-5656642-A | Peripheral vasodilating agent containing piperidine derivative as active ingredient | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-12 | — | — | US | disclosed |
| EP-0269043-B1 | PROCESS FOR PREPARING 3 PENTENOIC ACID ESTERS FROM 2-PENTENOIC ACID ESTERS | BASF Aktiengesellschaft (DE) | 1991-08-21 | — | — | EP | disclosed |
| US-4845269-A | Preparation of 3-pentenoates from 2-pentenoates | BASF AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | disclosed |
| EP-0269043-A2 | Process for preparing 3 pentenoic acid esters from 2-pentenoic acid esters | BASF Aktiengesellschaft (DE) | 1988-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221337-A1 | Process for Producing an Aromatic Unsaturated Compound | AHR, AR, ARSA | HCAR2 122/4885CA12 2713/4885AKR1B10 74/4885 |
| US-20260085072-A1 | METHOD FOR PREPARING INTERMEDIATE OF ADRENERGIC RECEPTOR AGONIST | ADRB2, ADRB1, ADRB3 | HCAR2 293/4885CA12 4698/4885AKR1B10 916/4885 |
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | CBS, ALDH7A1, CBR1 | HCAR2 174/4885CA12 741/4885AKR1B10 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.